It started around the same time as everything else. The joint pain that arrived in your early 40s. The fatigue that was different from tiredness. The rash, or the thyroid result that came back unusual, or the inflammatory markers your doctor could not fully explain. A year later you had a diagnosis for an autoimmune condition you had never had before, and no one drew a line between it and the hormonal changes that were happening simultaneously. The connection was never made.

The link between perimenopause and autoimmune conditions is one of the most under-discussed areas of women’s health, and it has significant implications for how women in midlife are assessed and treated. Autoimmune diseases affect women at a rate roughly nine times higher than men. Many of these conditions first appear or meaningfully worsen during perimenopause. The relationship between estrogen, immune function, and autoimmunity is complex, but the pattern is too consistent to be coincidence, and too important to remain invisible.

This article explains why the immune system is affected by perimenopause, which autoimmune conditions have the clearest links to hormonal change, what the mechanisms are, and what this should mean for your care.

How estrogen influences the immune system

Estrogen is an immunomodulatory hormone, meaning it actively regulates immune function. It is not a simple relationship of more estrogen equals more or less immune activity. Estrogen affects different parts of the immune system in different ways and in different directions, which is one reason why the relationship between hormonal change and autoimmunity is complex.

In general, estrogen promotes immune responsiveness and the activity of the adaptive immune system, which is the targeted, antigen-specific arm that produces antibodies. This is one reason why women tend to have stronger immune responses to infections and vaccines than men, and it is also one of the reasons why autoimmune conditions, which involve an overactive immune response directed at the body’s own tissues, are more common in women.

During perimenopause, estrogen levels fluctuate unpredictably rather than declining gradually. This hormonal volatility appears to create instability in immune regulation. The immune system’s tolerance mechanisms, which distinguish between self and non-self and prevent attack on the body’s own tissues, may be disrupted by this instability. The result is that conditions involving immune dysregulation, including autoimmune diseases and heightened inflammatory states, are more likely to emerge or worsen during this period.

Progesterone, which also declines during perimenopause, has generally anti-inflammatory effects. As progesterone falls, the balance between pro-inflammatory and anti-inflammatory immune activity shifts.

Which conditions are most commonly affected

Rheumatoid arthritis, an autoimmune condition in which the immune system attacks joint tissue, is one of the most clearly linked to hormonal change. Research has found that rheumatoid arthritis onset and flare activity correlate with hormonal transitions in women, including perimenopause. Women with existing rheumatoid arthritis frequently report worsening symptoms during the perimenopausal years.

Thyroid conditions, particularly Hashimoto’s thyroiditis, an autoimmune condition in which the immune system attacks the thyroid gland, show a strong association with perimenopause. Hashimoto’s is already far more common in women than men, and first onset or significant worsening during perimenopause is commonly reported. Because thyroid symptoms, including fatigue, weight changes, mood disruption, and cognitive fog, overlap significantly with perimenopause symptoms, both conditions are frequently missed or misattributed.

Lupus, an autoimmune disease affecting multiple organ systems, is predominantly a disease of women of reproductive age, and its activity is known to be influenced by estrogen. Some women experience changes in lupus disease activity during perimenopause.

Inflammatory bowel conditions, including Crohn’s disease and ulcerative colitis, have also been linked to hormonal transition in some research. Digestive symptoms that worsen during perimenopause may have an inflammatory or immune component that is not purely hormonal.

Multiple sclerosis, a neurological autoimmune condition, has some evidence linking relapse patterns to hormonal fluctuations. Women with MS often report changes in symptom patterns during perimenopause.

Why the connection is missed

Several factors contribute to the persistent disconnect between autoimmune diagnosis and hormonal assessment.

Medical specialization means that the rheumatologist treating your joint condition and the generalist or gynecologist who might discuss perimenopause are rarely in communication. Each clinician is focused on their domain. The hormonal context is rarely included in a rheumatology or immunology assessment, and perimenopause is rarely discussed in the context of autoimmune diagnosis.

Symptom overlap creates diagnostic confusion. Fatigue, joint pain, cognitive fog, sleep disruption, and mood changes are present in both perimenopause and many autoimmune conditions. When multiple explanations exist for the same symptom, medicine tends to investigate one explanation at a time, and the one chosen is usually the more pathological-sounding diagnosis rather than the hormonal one.

The culture of separate specialties also means that the research on hormone-immune interactions, though extensive, does not reliably reach clinicians in fields that primarily manage autoimmune conditions. The evidence exists. Its clinical application remains uneven.

What this means for your care

If you have an autoimmune condition and are in perimenopause, or if you developed an autoimmune condition during your 40s alongside other hormonal symptoms, it is worth having a direct conversation with your clinician about the possible connection.

Questions worth asking include: whether your hormonal status has been assessed in the context of your autoimmune condition, whether managing perimenopause symptoms, potentially including hormonal treatment, might have any effect on your immune condition, and whether your inflammatory markers are being monitored with the understanding that perimenopause may be contributing to their fluctuation.

It is also worth ensuring that any thyroid assessment you receive is thorough. TSH alone is not sufficient to identify Hashimoto’s thyroiditis; thyroid antibody testing, specifically anti-TPO antibodies, is required to detect the autoimmune component.

The relationship between your hormones and your immune system is real and clinically significant. You deserve care that takes both into account, and providers who understand that these systems do not operate in isolation.

Medical disclaimer: This article is for educational purposes only and is not medical advice. It is not a diagnosis, treatment plan, or substitute for care from a qualified healthcare professional. If you have concerning symptoms, seek medical care promptly.